EDITORIAL
Published on 07 Oct 2020
Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response
doi 10.3389/fphar.2020.598261
- 1,430 views
- Frontiers in Pharmacology
- Pharmacogenetics and Pharmacogenomics
- Research Topics
- Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response
Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response
12k
Total downloads
51k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 24 Jul 2020
Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response
doi 10.3389/fonc.2020.01028
- 3,083 views
- 30 citations
CASE REPORT
Published on 08 Apr 2020
Abiraterone Rechallenge Based on Sequential Testing of Androgen Receptor Splice Variant 7 Expression in Circulating Tumor Cells: A Case Report
doi 10.3389/fonc.2020.00495
- 3,167 views
- 6 citations
MINI REVIEW
Published on 27 Feb 2020
Single Cell Transcriptome in Colorectal Cancer—Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor Cells
doi 10.3389/fphar.2020.00135
- 20,280 views
- 38 citations
CASE REPORT
Published on 10 Feb 2020
Circulating Tumor DNA-Based Detection of Microsatellite Instability and Response to Immunotherapy in Pancreatic Cancer
doi 10.3389/fphar.2020.00023
- 5,639 views
- 8 citations
CASE REPORT
Published on 07 Feb 2020
Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib
doi 10.3389/fphar.2020.00036
- 2,447 views
- 11 citations
REVIEW
Published on 24 Jan 2020
Leukobiopsy – A Possible New Liquid Biopsy Platform for Detecting Oncogenic Mutations
doi 10.3389/fphar.2019.01608
- 2,322 views
- 9 citations
ORIGINAL RESEARCH
Published on 15 Oct 2019
Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer
doi 10.3389/fonc.2019.01015
- 4,096 views
- 50 citations
REVIEW
Published on 14 Aug 2019
Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
doi 10.3389/fonc.2019.00740
- 3,707 views
- 24 citations
Published in
Frontiers in Pharmacology
- Pharmacogenetics and Pharmacogenomics
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Genetics
- 2.8 impact factor
- 5.5 citescore
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 51kTopic views
- 36kArticle views
- 12kArticle downloads